MD-2 Antibodies

Santa Cruz Biotechnology offers a broad range of MD-2 monoclonal antibodies for research focused on understanding immune response mechanisms. MD-2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MD-2 is a critical component of the Toll-like receptor 4 (TLR4) complex, playing a vital role in the recognition of lipopolysaccharides (LPS) from Gram-negative bacteria. This interaction is essential for initiating innate immune responses and modulating inflammation. Understanding the function of MD-2 is crucial for developing therapeutic strategies against various infectious diseases and inflammatory conditions. MD-2 monoclonal antibodies enable researchers to explore cellular signaling pathways involved in immune response regulation. Investigating MD-2's role in TLR4 signaling can reveal new insights into inflammatory disease mechanisms. Research utilizing MD-2 monoclonal antibodies contributes to advancing immunology studies and developing potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of immune system regulation and disease pathogenesis.